224 related articles for article (PubMed ID: 28552603)
21. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
[TBL] [Abstract][Full Text] [Related]
22. PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer.
Wang Z; Kong J; Wu Y; Zhang J; Wang T; Li N; Fan J; Wang H; Zhang J; Ling R
Breast Cancer Res Treat; 2018 Apr; 168(2):531-542. PubMed ID: 29185119
[TBL] [Abstract][Full Text] [Related]
23. Salinomycin inhibits osteosarcoma by targeting its tumor stem cells.
Tang QL; Zhao ZQ; Li JC; Liang Y; Yin JQ; Zou CY; Xie XB; Zeng YX; Shen JN; Kang T; Wang J
Cancer Lett; 2011 Dec; 311(1):113-21. PubMed ID: 21835542
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor β1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma.
Zhang H; Wu H; Zheng J; Yu P; Xu L; Jiang P; Gao J; Wang H; Zhang Y
Stem Cells; 2013 Mar; 31(3):433-46. PubMed ID: 23225703
[TBL] [Abstract][Full Text] [Related]
25. Cancer stem cells in osteosarcoma.
Brown HK; Tellez-Gabriel M; Heymann D
Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
[TBL] [Abstract][Full Text] [Related]
27. Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization.
Mallappa S; Neeli PK; Karnewar S; Kotamraju S
Mol Carcinog; 2019 Jul; 58(7):1118-1133. PubMed ID: 30834613
[TBL] [Abstract][Full Text] [Related]
28. LY294002 induces G0/G1 cell cycle arrest and apoptosis of cancer stem-like cells from human osteosarcoma via down-regulation of PI3K activity.
Gong C; Liao H; Wang J; Lin Y; Qi J; Qin L; Tian LQ; Guo FJ
Asian Pac J Cancer Prev; 2012; 13(7):3103-7. PubMed ID: 22994717
[TBL] [Abstract][Full Text] [Related]
29. Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.
Xia YZ; Yang L; Xue GM; Zhang C; Guo C; Yang YW; Li SS; Zhang LY; Guo QL; Kong LY
Oncotarget; 2016 Aug; 7(35):56371-56382. PubMed ID: 27486760
[TBL] [Abstract][Full Text] [Related]
30. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
31. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
[TBL] [Abstract][Full Text] [Related]
32. SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition.
Wang W; Chen D; Zhu K
J Exp Clin Cancer Res; 2018 Feb; 37(1):37. PubMed ID: 29475441
[TBL] [Abstract][Full Text] [Related]
33. Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy.
Zhao B; Luo J; Wang Y; Zhou L; Che J; Wang F; Peng S; Zhang G; Shang P
Oxid Med Cell Longev; 2019; 2019():9290728. PubMed ID: 31827709
[TBL] [Abstract][Full Text] [Related]
34. Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs.
Fromigué O; Hamidouche Z; Marie PJ
J Pharmacol Exp Ther; 2008 May; 325(2):595-600. PubMed ID: 18252811
[TBL] [Abstract][Full Text] [Related]
35. Emerging roles of Krüppel-like factor 4 in cancer and cancer stem cells.
Ding B; Liu P; Liu W; Sun P; Wang CL
Asian Pac J Cancer Prev; 2015; 16(9):3629-33. PubMed ID: 25987013
[TBL] [Abstract][Full Text] [Related]
36. Targeting hedgehog-GLI-2 pathway in osteosarcoma.
Yang W; Liu X; Choy E; Mankin H; Hornicek FJ; Duan Z
J Orthop Res; 2013 Mar; 31(3):502-9. PubMed ID: 22968906
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in Osteosarcoma.
Lu B; He Y; He J; Wang L; Liu Z; Yang J; Gao Z; Lu G; Zou C; Zhao W
Mol Cancer Res; 2020 Jan; 18(1):57-67. PubMed ID: 31615908
[TBL] [Abstract][Full Text] [Related]
38. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract][Full Text] [Related]
39. TGF-β1-induced CK17 enhances cancer stem cell-like properties rather than EMT in promoting cervical cancer metastasis via the ERK1/2-MZF1 signaling pathway.
Wu L; Han L; Zhou C; Wei W; Chen X; Yi H; Wu X; Bai X; Guo S; Yu Y; Liang L; Wang W
FEBS J; 2017 Sep; 284(18):3000-3017. PubMed ID: 28703907
[TBL] [Abstract][Full Text] [Related]
40. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
Hu T; Fei Z; Su H; Xie R; Chen L
Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
